|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
EP1541682A3
(en)
|
1988-09-02 |
2005-07-06 |
Dyax Corp. |
Generation and selection of recombinant varied binding proteins
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US6291158B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
JPH06508511A
(ja)
|
1990-07-10 |
1994-09-29 |
ケンブリッジ アンティボディー テクノロジー リミティド |
特異的な結合ペアーの構成員の製造方法
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
DE69233769D1
(de)
|
1991-03-01 |
2009-09-24 |
Dyax Corp |
Chimäres Protein mit Mikroprotein mit zwei oder mehr Disulfidbindungen und Ausgestaltungen davon
|
|
ATE414768T1
(de)
|
1991-04-10 |
2008-12-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US7566768B1
(en)
*
|
1995-10-26 |
2009-07-28 |
The Johns Hopkins University School Of Medicine |
Promyostatin peptides and methods of using same
|
|
ES2201076T3
(es)
|
1993-03-19 |
2004-03-16 |
The Johns Hopkins University School Of Medicine |
Factor-8 de diferenciacion del crecimiento.
|
|
US5994618A
(en)
*
|
1997-02-05 |
1999-11-30 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 transgenic mice
|
|
US7393682B1
(en)
|
1993-03-19 |
2008-07-01 |
The Johns Hopkins University School Of Medicine |
Polynucleotides encoding promyostatin polypeptides
|
|
DK0776337T3
(da)
|
1994-07-08 |
2005-12-12 |
Univ Johns Hopkins Med |
Vækstdifferentieringsfaktor-11
|
|
US20030167492A1
(en)
|
1994-07-08 |
2003-09-04 |
Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
|
|
US6891082B2
(en)
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
|
US6656475B1
(en)
|
1997-08-01 |
2003-12-02 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
|
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
|
CA2364484A1
(en)
|
1999-03-09 |
2000-09-14 |
University Of Southern California |
Method of promoting myocyte proliferation and myocardial tissue repair
|
|
CA2396372A1
(en)
|
2000-01-28 |
2001-08-02 |
Novo Nordisk A/S |
Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity
|
|
DE60143798D1
(de)
|
2000-06-16 |
2011-02-17 |
Cambridge Antibody Tech |
Immunspezifisch bindende antikörper gegen blys
|
|
AU2011244851A1
(en)
|
2000-07-27 |
2011-11-24 |
The John Hopkins University School Of Medicine |
Promyostatin peptides and methods of using same
|
|
US7320789B2
(en)
*
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
|
ES2288900T3
(es)
|
2001-10-05 |
2008-02-01 |
Affimed Therapeutics Ag |
Anticuerpo de origen humano para inhibir la agregacion de trombocitos.
|
|
US8455627B2
(en)
|
2001-10-05 |
2013-06-04 |
Affimed Therapeutics, Ag |
Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa
|
|
AR040603A1
(es)
|
2002-07-19 |
2005-04-13 |
Abbott Lab S A |
El uso de un anticuerpo anti-tnfalfa neutralizador de alta afinidad en la fabricacion de un medicamento y conjunto de elementos
|
|
JP2006507356A
(ja)
|
2002-09-16 |
2006-03-02 |
ワイエス |
ミオスタチンのメタロプロテアーゼ活性化およびミオスタチン活性の調節方法
|
|
AR047392A1
(es)
*
|
2002-10-22 |
2006-01-18 |
Wyeth Corp |
Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
|
|
US7285269B2
(en)
|
2002-12-02 |
2007-10-23 |
Amgen Fremont, Inc. |
Antibodies directed to tumor necrosis factor
|
|
KR20130036378A
(ko)
|
2002-12-20 |
2013-04-11 |
암겐 인코포레이티드 |
미오스타틴을 저해하는 결합제
|
|
SG153874A1
(en)
|
2003-12-31 |
2009-07-29 |
Schering Plough Ltd |
Neutralizing epitope-based growth enhancing vaccine
|
|
EP1729793B1
(en)
|
2004-03-02 |
2015-07-22 |
Acceleron Pharma Inc. |
Alk7 and myostatin inhibitors for muscle wasting disorders
|
|
US20070178095A1
(en)
|
2004-03-23 |
2007-08-02 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
|
US7850962B2
(en)
|
2004-04-20 |
2010-12-14 |
Genmab A/S |
Human monoclonal antibodies against CD20
|
|
US20100183695A1
(en)
|
2004-05-27 |
2010-07-22 |
John Knopf |
Cerberus/coco derivatives and uses thereof
|
|
AU2005271523B2
(en)
|
2004-08-03 |
2011-09-15 |
Dyax Corp. |
hk1-binding proteins
|
|
WO2006081139A2
(en)
|
2005-01-26 |
2006-08-03 |
Abgenix, Inc. |
Antibodies against interleukin-1 beta
|
|
US20060216279A1
(en)
|
2005-03-22 |
2006-09-28 |
Glass David J |
Myostatin inhibiting fusion polypeptides and therapeutic methods thereof
|
|
BRPI0610248A2
(pt)
|
2005-04-25 |
2010-06-08 |
Pfizer |
anticorpos contra miostatina, composição farmacêutica compreendendo os mesmos, linhas celulares que os produzem , moléculas de ácido nucleico codificantes dos mesmos bem como seus usos
|
|
EP1915397B1
(en)
*
|
2005-08-19 |
2015-01-14 |
Wyeth LLC |
Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders
|
|
ES2533464T3
(es)
|
2005-10-06 |
2015-04-10 |
Eli Lilly And Company |
Anticuerpos anti-miostatina
|
|
UA92504C2
(en)
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
|
WO2007061995A2
(en)
|
2005-11-21 |
2007-05-31 |
Novartis Ag |
Biomarkers for statin-induced myopathy or rhabdomyolysis
|
|
US8097596B2
(en)
*
|
2006-06-30 |
2012-01-17 |
Lakewood-Amedex, Inc. |
Compositions and methods for the treatment of muscle wasting
|
|
AU2007279456A1
(en)
|
2006-08-03 |
2008-02-07 |
Myostin Therapeutics Pty Ltd |
Myostatin antagonists
|
|
UA98308C2
(en)
|
2006-09-05 |
2012-05-10 |
Эли Лилли Энд Компани |
Anti-myostatin antibody
|
|
ES2569365T3
(es)
|
2006-11-29 |
2016-05-10 |
Nationwide Children's Hospital |
Inhibición de miostatina para la potenciación de músculo y/o la mejora de la función muscular
|
|
WO2008103471A2
(en)
|
2007-02-23 |
2008-08-28 |
The Trustees Of Columbia University In The City Of New York |
Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
|
|
WO2008119426A1
(en)
|
2007-03-30 |
2008-10-09 |
Merck Patent Gmbh |
Birefingent layer with negative optical dispersion
|
|
CA2688563A1
(en)
|
2007-06-01 |
2008-12-11 |
Biogen Idec Ma Inc. |
Cripto binding molecules
|
|
TW200918553A
(en)
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
|
PE20091163A1
(es)
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
|
UY32341A
(es)
|
2008-12-19 |
2010-07-30 |
Glaxo Group Ltd |
Proteínas de unión antígeno novedosas
|
|
KR101558642B1
(ko)
|
2009-02-24 |
2015-10-12 |
솔크 인스티튜트 포 바이올로지칼 스터디즈 |
Ｔｇｆ-베타 슈퍼패밀리의 설계자 리간드
|
|
EA027071B1
(ru)
|
2009-04-27 |
2017-06-30 |
Новартис Аг |
АНТИТЕЛО К ActRIIB И СОДЕРЖАЩАЯ ЕГО КОМПОЗИЦИЯ
|
|
MX385318B
(es)
|
2009-06-08 |
2025-03-18 |
Acceleron Pharma Inc |
Metodos para aumentar adipocitos termogenicos.
|
|
US8945511B2
(en)
|
2009-06-25 |
2015-02-03 |
Paul Weinberger |
Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
|
|
BR112012007563A2
(pt)
|
2009-10-01 |
2019-09-24 |
Covita Ltd |
peptídeos sintéticos antagonistas de miostatina
|
|
ES2993335T3
(en)
|
2010-03-10 |
2024-12-27 |
Genmab As |
Monoclonal antibodies against c-met
|
|
TWI667257B
(zh)
|
2010-03-30 |
2019-08-01 |
中外製藥股份有限公司 |
促進抗原消失之具有經修飾的ＦｃＲｎ親和力之抗體
|
|
JO3340B1
(ar)
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
|
UY33421A
(es)
|
2010-06-03 |
2011-12-30 |
Glaxo Wellcome House |
Proteinas de union al antígeno humanizados
|
|
SG187867A1
(en)
|
2010-08-16 |
2013-03-28 |
Amgen Inc |
Antibodies that bind myostatin, compositions and methods
|
|
CA2852127C
(en)
|
2011-11-11 |
2020-10-27 |
Duke University |
Combination drug therapy for the treatment of solid tumors
|
|
RS56796B1
(sr)
|
2011-11-14 |
2018-04-30 |
Regeneron Pharma |
Kompozicije i postupci za uvećanje mišićne mase i jačine mišića specifičnim antagonizovanjem gdf8 i/ili aktivina a
|
|
US20130178454A1
(en)
|
2011-11-17 |
2013-07-11 |
Shalender Bhasin |
Combination of testosterone and ornithine decarboxylase (odc) inhibitors
|
|
WO2013148284A1
(en)
|
2012-03-29 |
2013-10-03 |
Genentech, Inc. |
Antibodies that bind to a pcsk9 cleavage site and methods of use
|
|
WO2013165972A2
(en)
|
2012-04-30 |
2013-11-07 |
Cell Signaling Technology, Inc. |
Anti-hepatitis b virus antibodies and use thereof
|
|
CN104487453B
(zh)
*
|
2012-06-15 |
2018-09-28 |
辉瑞公司 |
经改良的抗gdf-8的拮抗剂抗体及其用途
|
|
JP2016500704A
(ja)
|
2012-11-06 |
2016-01-14 |
スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． |
細胞シグナル伝達を変調するための組成物及び方法
|
|
SMT202100008T1
(it)
|
2013-05-06 |
2021-03-15 |
Scholar Rock Inc |
Composizioni e metodi per la modulazione di fattore di crescita
|
|
EP2853898B1
(en)
|
2013-09-27 |
2017-01-04 |
Medizinische Hochschule Hannover |
Analysis of myostatin in serum
|
|
EP3068407A1
(en)
*
|
2013-11-11 |
2016-09-21 |
Sirna Therapeutics, Inc. |
Systemic delivery of myostatin short interfering nucleic acids (sina) conjugated to a lipophilic moiety
|
|
WO2015195094A1
(en)
|
2014-06-17 |
2015-12-23 |
Ember Therapeutics, Inc. |
Anti-activin and nati-myostatin antibodies and methods of using the same
|
|
EP3215175A4
(en)
*
|
2014-11-06 |
2018-06-27 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
|
WO2016073906A2
(en)
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Transforming growth factor-related immunoassays
|
|
TWI656133B
(zh)
|
2014-12-19 |
2019-04-11 |
日商中外製藥股份有限公司 |
抗肌抑素之抗體、含變異Ｆｃ區域之多胜肽及使用方法
|
|
JP6877357B2
(ja)
|
2015-04-15 |
2021-05-26 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
Ｇｄｆ８阻害剤を用いて、強度及び機能を増加させる方法
|
|
IL305148A
(en)
|
2015-09-15 |
2023-10-01 |
Scholar Rock Inc |
Anti-pro/hidden myostatin antibodies and their uses
|
|
JP2019504064A
(ja)
|
2016-01-08 |
2019-02-14 |
スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． |
抗プロ／潜在型ミオスタチン抗体およびその使用方法
|
|
EP3785728A3
(en)
|
2016-06-13 |
2021-04-28 |
Scholar Rock, Inc. |
Use of myostatin inhibitors and combination therapies
|
|
JOP20190152A1
(ar)
|
2016-12-21 |
2019-06-20 |
Novartis Ag |
مضادات الميوستاتين، الآكتيفين أو مستقبلات الآكتيفين للاستخدام في علاج السمنة والحالات ذات الصلة
|
|
JP7198757B2
(ja)
|
2017-01-06 |
2023-01-04 |
スカラー ロック インコーポレイテッド |
ミオスタチン活性化の阻害により代謝疾患を処置するための方法
|